Indian Journal of Pharmacy and Pharmacology

Print ISSN: 2393-9079

Online ISSN: 2393-9087

CODEN : IJPPTK

Indian Journal of Pharmacy and Pharmacology (IJPP) open access, peer-reviewed quarterly journal publishing since 2014 and is published under auspices of the Innovative Education and Scientific Research Foundation (IESRF), aim to uplift researchers, scholars, academicians, and professionals in all academic and scientific disciplines. IESRF is dedicated to the transfer of technology and research by publishing scientific journals, research content, providing professional’s membership, and conducting conferences, seminars, and award programs. With more...

Article type

Original Article


Article page

45-51


Authors Details

Rhythm , Nirav Asarawala, Barna Ganguly*


Article Metrics


View Article As

 


Downlaod Files

   






Article statistics

Viewed: 1547

PDF Downloaded: 1146


Hormonal treatment in patients of breast cancer and their quality of life in western Indian scenario


Original Article

Author Details : Rhythm , Nirav Asarawala, Barna Ganguly*

Volume : 6, Issue : 2, Year : 2019

Article Page : 45-51

https://doi.org/10.18231/j.ijpp.2019.011



Suggest article by email

Get Permission

Abstract

Context: Long term use of anti-hormonal therapy in breast cancers is effective for extending long term survival rates but simultaneously can lead to various side effects affecting quality of life.
Aims: Aim of this study was to assess the utilization of hormonal treatment in patients suffering from breast cancer with specific objective of reviewing their quality of life with relation to side effects.
Settings and Design: This was an OPD based cross sectional study, conducted in Shree Krishna Hospital, Karamsad.
Methods and Materials: Prior permission from institutional ethics committee was taken. Utilization part of the study was a record based study, from the case files available in record section of cancer OPD. For quality of life part of the study, written informed consent was taken from the participants and were interviewed according to quality of life questionnaires.
Statistical Analysis Used: Data were analyzed as per descriptive statistics and results were presented in form of percentage and range. Mean scores for various quality of life subscales were calculated using EORTC scoring manual.
Results: Out of total 38 patients of breast cancer, 26(68.42%) patients were on treatment with letrozole, 12(31.57%) were on tamoxifen. We found better role functioning and cognitive functioning subscales in breast cancer patients of tamoxifen group as reflected in the highest mean score of 93.74 in functional scale. Mean sexual functioning scores in both letrozole and tamoxifen groups were on lower side. Percentage of patients experiencing systemic therapy side effect (dry mouth, hot flushes, hair loss, headache, dysgeusia) were found to be more in tamoxifen group.
Conclusions: Overall, the parameters of quality of life in breast cancer patients on hormonal therapy, were found to be in better side, except for sexual functioning scores which were on lower side.

Keywords: Breast cancer, Hormonal therapy, Quality of life.


How to cite : Rhythm, Asarawala N, Ganguly B, Hormonal treatment in patients of breast cancer and their quality of life in western Indian scenario. Indian J Pharm Pharmacol 2019;6(2):45-51

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.